Publications – Last Five Years
View all of Dr. Jain's publications in PubMed
“Apigenin modulates dendritic cell activities and curb inflammation via RelB inhibition in the context of neuroinflammatory diseases”
Ginwala, R., Bhavsar, R. Moore, P., Bernui, M., Singh, Bearoff, F., Nagarkatti, M., Z. K. Khan, and P. Jain
Journal of Neuroimmune Pharmacology, 16:403-424 (2021)
“Risk Factors Associated with the Clinical Outcomes of COVID‐19 and Its Variants in the Context of Cytokine Storm and Therapeutics/Vaccine Development Challenges”
Hahn J, Tipparaju P, Mulhurkar T, Lin E, Mischley, V., Kulkarni, R., Bolton, A., Byrareddy, S., and P. Jain
Vaccines, 9: 938-969. https://doi.org/10.3390/vaccines9080938 (2021)
“Phenotypic and Functional Analyses Guiding Combination Immune Checkpoint Immunotherapy Strategies in Chronic HTLV-1 Infection. Frontiers in Immunology”
Clements, D., Crumley, B., Chew, G., Davis, E., Bruhn, R., Murphy, E., Ndhlovu, L., and P. Jain
Frontiers in Immunology, 12:1-14 (2021)
“Can soluble immune checkpoint molecules on exosomes mediate inflammation?”
Joseph, J., Rahmani, B., Cole, Y., Puttagunta, N., Lin, E., Khan, Z. K., and P. Jain
Journal of Neuroimmune Pharmacology, In press (2021)
“Advanced Concepts in Human Immunology: Prospects for Disease Control” (Book)
P. Jain (Chief Editor) and L. Ndhlovu (Co-editor)
Springer International Publishing, ISBN: 9783030339456 (2020)
“Human T-cell Leukemia Virus Type 1 and Strongyloides stercoralis: Partners in Pathogenesis”
Dykie, A., Wijesinghe, T., Rabson, A., Madugula, K., Farinas, C., Wilson, S., Abraham, D., and P. Jain
Pathogens, 9:904-924 (2020)
“Potential Role of Flavonoids in Treating Chronic Inflammatory Diseases with a Special Focus on the Anti-Inflammatory Activity of Apigenin”
Ginwala, R., Bhavsar, R., Chigbu, D., and P. Jain
Antioxidants, 8: 35-63 (2019)
“Human T-cell leukemia virus type 1 and Zika virus: Tale of two re-emerging viruses with neuropathological sequelae of public health concern”
Chigbu, D., Jain, P., Crumley, B., Patel, D., and Z. K. Khan
Journal of NeuroVirology, 25:289-300 (2019)
“MEF-2 isoforms (A-D): roles in diseases and target for novel therapies”
Madugula, K., Mulherkar, R., Z. K. Khan, Chigbu, D., Patel, D., Harhaj, E., and P. Jain
Oncotarget, 10: 2755-2787 (2019)
“In vivo and in vitro immunogenicity of novel MHC class I presented epitopes to confer protective immunity against chronic HTLV-1 infection”
Mulherkar, R., Karabudak, A., Ginwala, R., Huang, X., Rowan, A., Philip, R., Murphy, E., Clements, D., Ndhlovu, L., Khan, Z. K., and P. Jain
Vaccine, 36: 5046-5057 (2018)
“FDC:TFH Interactions within Cervical Lymph Nodes of SIV-Infected Rhesus Macaques”
Dave RS, Sharma RK, Muir RR, Haddad E, Gumber S, Villinger F, Nehra AP, Khan ZK, Wigdahl B, Ansari AA, Byrareddy SN, and Jain P
Journal of Neuroimmune Pharmacology, 13(2):204-218 (2018)
“Follicular Dendritic Cells of Lymph Nodes as Human Immunodeficiency Virus/Simian Immunodeficiency Virus Reservoirs and Insights on Cervical Lymph Node”
Dave RS, Jain P, and Byrareddy SN
Frontiers in Immunology, 9:805 (April 19, 2018)
“Antibody blockade of CLEC12A delays EAE onset and attenuates disease severity by impairing myeloid cell CNS infiltration and restoring positive immunity”
Sagar D, Singh NP, Ginwala R, Huang X, Philip R, Nagarkatti M, Nagarkatti P, Neumann K, Ruland J, Andrews AM, Ramirez SH, Khan ZK, and Jain P
Scientific Reports, 7(1):2707 (2017)
“HTLV-1 Infection and Neuropathogenesis in the Context of Rag1-/-γc-/- (RAG1-Hu) and BLT Mice”
Ginwala R, Caruso B, Khan ZK, Pattekar A, Chew GM, Corley MJ, Loonawat R, Jacobson S, Sreedhar S, Ndhlovu LC, and Jain P
Journal of Neuroimmune Pharmacology, the official journal of the Society on NeuroImmune Pharmacology, 12(3):504-520 (2017)
“Stromal cyclin D1 promotes heterotypic immune signaling and breast cancer growth”
Pestell TG, Jiao X, Kumar M, Peck AR, Prisco M, Deng S, Li Z, Ertel A, Casimiro MC, Ju X, Di Rocco A, Di Sante G, Katiyar S, Shupp A, Lisanti MP, Jain P, Wu K, Rui H, Hooper DC, Yu Z, Goldman AR, Speicher DW, Laury-Kleintop L, and Pestell RG
Oncotarget, 8(47):81754-81775 (2017)